In the News Archives - Page 2 of 7 - Alzheon | Preserving Future Memories

13 Jul, 2023

Venture Capitalists Fund New Generation of Alzheimer’s Drugs

alzheon2024-06-06T17:58:07-04:00July 13th, 2023|Tags: WSJ|

10 May, 2023

Understanding Patient Characteristics of Phase 3 APOLLOE4 Trial of ALZ-801 in Alzheimer Disease: John Hey, PhD

alzheon2023-05-31T18:05:53-04:00May 10th, 2023|

6 May, 2023

Eli Lilly’s Donanemab: The Anti-Amyloid Saga Continues

alzheon2023-07-31T15:59:29-04:00May 6th, 2023|

28 Apr, 2023

AAN 2023: ALZ-801 for Alzheimer’s found to improve cognition in trial

alzheon2023-05-03T11:24:17-04:00April 28th, 2023|

28 Apr, 2023

Oral Anti-Amyloid Shows Disease-Modifying Potential: Phase 2 Data

alzheon2023-05-03T12:05:29-04:00April 28th, 2023|

20 Mar, 2023

The New Era of Life Sciences

alzheon2024-08-02T09:47:38-04:00March 20th, 2023|

12 Mar, 2023

Why lecanemab’s success spells the revival of small-molecule Alzheimer’s treatments

alzheon2024-05-15T16:38:27-04:00March 12th, 2023|

21 Feb, 2023

Newsweek Investment Report: Interview with Dr. Martin Tolar, President & CEO of Alzheon, Inc.

alzheon2023-04-16T12:18:58-04:00February 21st, 2023|

17 Feb, 2023

‘It’s night and day’: Biogen’s new Alzheimer’s drug may spur more investment in fighting the disease

alzheon2024-08-02T08:55:07-04:00February 17th, 2023|

15 Feb, 2023

I interview Dr. Martin Tolar, Founder, CEO and President of Alzheon on the Phase 3 trial going on right now

alzheon2023-02-16T12:37:20-05:00February 15th, 2023|